Clinical Trial Update: eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of depemokimab as early therapy for chronic obstructive pulmonary disease with Type 2 inflammation. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Depemokimab (depemokimab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: RECRUITING